Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

Magic Mushroom Drug Helps Cancer Patients Chill Out

Duration: 00:54s - Published: < > Embed
News video: Magic Mushroom Drug Helps Cancer Patients Chill OutThe "magic mushroom" drug psilocybin can help cancer patients relax and feel less distressed about their disease, two teams of doctors reported Thursday. The drug eased anxiety and depression in 80 percent of the patients who took it in the studies, and many described their one-time sessions as ranking among the most meaningful experiences of their lives. Dr. Stephen Ross, director of addiction psychiatry at New York University's Langone Medical Center, gave the following statement to NBC news.

Share on
Share on
Post on 
Share by

Recent related news

'First in human' trial defines safe dosage for small molecule drug ONC201 for solid cancer tumors

A ‘first in human’ clinical trial examining the small molecule drug ONC201 in cancer patients...
Science Daily - Science

Eric Lefkofsky's Tempus will use data to help UChicago battle breast cancer

Tempus, the cancer fighting startup from Groupon founder Eric Lefkofsky, wants to give doctors at the...
bizjournals - Business

Allergan to put forward new acne drug after good trials

Allergan PLC (NYSE:AGN) and Paratek Pharmaceuticals Inc (NASDAQ:PRTK) are to file later this year for...
Proactive Investors - Business

Researchers discover key to drug resistance in common breast cancer treatment

Three-quarters of all breast cancer tumors are driven by the hormone estrogen. These tumors are...
Science Daily - Science

Lilly's breast cancer drug combination succeeds in key study

(Reuters) - U.S. drugmaker Eli Lilly and Co said on Monday a combination of its experimental breast...
Reuters - HealthAlso reported by •Reuters India

Rhode Island hospital group partners with Dana-Farber Cancer Institute

Rhode Island hospital system Lifespan Cancer Institute had signed a five-year agreement with...
bizjournals - Business

Patients' reports may aid prostate cancer treatment choice

CHICAGO (AP) — Men with early-stage prostate cancer face a dizzying quandary over which treatment...
SeattlePI.com - Health

Moleculin Receives Orphan Drug Designation for Annamycin for the Treatment of Acute Myeloid Leukemia

HOUSTON, TX--(Marketwired - March 22, 2017) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or...
Marketwired - Press Releases

Novartis cancer drug combo developed in Cambridge shows early promise

***EMBARGOED UNTIL 2PM WED*** An experimental cancer drug developed by Cambridge-based Novartis...
bizjournals - Business

EMD Serono nabs FDA approval for rare skin cancer drug

The FDA has approved a drug for a rare form of skin cancer that was developed in part by researchers...
bizjournals - Business

You Might Like

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+